TEMAZEPAM CAPSULES USP — Class III drug recall D-0326-2017
Terminated recall by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals, reported 2017-01-11, distributed nationwide. Failed Stability Specifications
| Recall number | D-0326-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals, Huntsville, AL, United States |
| Recall initiated | 2016-12-22 |
| Classified | 2017-01-03 |
| Reported by FDA | 2017-01-11 |
| Terminated | 2017-09-18 |
| Distributed | Nationwide (US) |
| Quantity | 1,200 bottles |
| Reason classes | specification failure |
| NDC | 00603-5891-21 |
Product
TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21
Reason for recall
Failed Stability Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0326-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.